Novel spiroisatin-pyranopyrazole hybrids as anticancer agents with TrkC inhibitory potential.
Saved in:
| Title: | Novel spiroisatin-pyranopyrazole hybrids as anticancer agents with TrkC inhibitory potential. |
|---|---|
| Authors: | Mohammadi S; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Mortazavi M; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Poustforoosh A; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Moosavi F; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Saso L; Department of Physiology and Pharmacology 'Vittorio Erspamer', Sapienza University of Rome, Rome, Italy., Edraki N; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Firuzi O; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. |
| Source: | Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2025 Nov; Vol. 43 (18), pp. 10931-10944. Date of Electronic Publication: 2025 Mar 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-0254 (Electronic) Linking ISSN: 07391102 NLM ISO Abbreviation: J Biomol Struct Dyn Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-0254 |
|---|---|
| DOI: | 10.1080/07391102.2025.2472404 |
